Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02719028
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Golden Biotechnology Corporation
- Registry
-
NCT02719028
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT02719028. Randomized; double masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2018-09-27 (actual). Results posted on 2019-12-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
- Condition
- Hyperlipidemias
- Intervention (Drug)
- Antroquinonol
- Intervention (Drug)
- placebo
- Lead sponsor
- Golden Biotechnology Corporation
Record details
- Record id
cardio:ct-nct02719028- Content hash
a6cd954d43e2614c07566aed391ede52caa8f6b280c837606c0f36f6ceacee20